Study of NGR-hTNF as Single Agent in Patients Affected by Advanced or Metastatic Hepatocellular Carcinoma (HCC)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2006
The main objective of the trial is to document the progression free survival (PFS) in advanced or metastatic hepatocellular carcinoma patients treated with NGR-hTNF as single agent. Safety will be established by clinical and laboratory assessment according to NCI-CTC criteria
Epistemonikos ID: 1408b6d13fcfa61850a956e37374903fd2a05d03
First added on: May 04, 2024